278 related articles for article (PubMed ID: 34796242)
1. The Longest Persistence of Viable SARS-CoV-2 With Recurrence of Viremia and Relapsing Symptomatic COVID-19 in an Immunocompromised Patient-A Case Study.
Sepulcri C; Dentone C; Mikulska M; Bruzzone B; Lai A; Fenoglio D; Bozzano F; Bergna A; Parodi A; Altosole T; Delfino E; Bartalucci G; Orsi A; Di Biagio A; Zehender G; Ballerini F; Bonora S; Sette A; De Palma R; Silvestri G; De Maria A; Bassetti M
Open Forum Infect Dis; 2021 Nov; 8(11):ofab217. PubMed ID: 34796242
[TBL] [Abstract][Full Text] [Related]
2. Isolation of SARS-CoV-2 in Viral Cell Culture in Immunocompromised Patients With Persistently Positive RT-PCR Results.
Sung A; Bailey AL; Stewart HB; McDonald D; Wallace MA; Peacock K; Miller C; Reske KA; O'Neil CA; Fraser VJ; Diamond MS; Burnham CD; Babcock HM; Kwon JH
Front Cell Infect Microbiol; 2022; 12():804175. PubMed ID: 35186791
[TBL] [Abstract][Full Text] [Related]
3. Prolonged viral shedding of SARS-CoV-2 in two immunocompromised patients, a case report.
Niyonkuru M; Pedersen RM; Assing K; Andersen TE; Skov MN; Johansen IS; Madsen LW
BMC Infect Dis; 2021 Aug; 21(1):743. PubMed ID: 34344321
[TBL] [Abstract][Full Text] [Related]
4. Long-term SARS-CoV-2 Asymptomatic Carriage in an Immunocompromised Host: Clinical, Immunological, and Virological Implications.
Spinicci M; Mazzoni A; Coppi M; Antonelli A; Salvati L; Maggi L; Basile G; Graziani L; Di Lauria N; Di Pilato V; Kiros ST; Beccastrini E; Saccardi R; Angileri M; Cecchi M; Cusi MG; Rossolini GM; Annunziato F; Bartoloni A; Parronchi P
J Clin Immunol; 2022 Oct; 42(7):1371-1378. PubMed ID: 35779200
[TBL] [Abstract][Full Text] [Related]
5. Persistent viral shedding of severe acute respiratory syndrome coronavirus 2 after treatment with bendamustine and rituximab: A case report.
Arai T; Mukai S; Kazama R; Ogawa Y; Nishida K; Hatanaka K; Gohma I
J Infect Chemother; 2022 Jun; 28(6):810-813. PubMed ID: 35115239
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of SARS-CoV-2 in an immunocompromised patient with persistent infection for 245 days: A case report.
Overbeck V; Taylor BP; Turcinovic J; Qiu X; Schaeffer B; Seitz S; Curry SR; Hanage WP; Connor JH; Kuppalli K
Heliyon; 2024 Jan; 10(1):e23699. PubMed ID: 38223743
[TBL] [Abstract][Full Text] [Related]
7. Prolonged SARS-CoV-2 infection associated with long-term corticosteroid use in a patient with impaired B-cell immunity.
Morishita M; Suzuki M; Matsunaga A; Ishizhima K; Yamamoto T; Kuroda Y; Kanno T; Tsujimoto Y; Ishida A; Hashimoto M; Ishii S; Takasaki J; Naka G; Iikura M; Izumi S; Suzuki T; Maeda K; Ishizaka Y; Hojo M; Sugiyama H
J Infect Chemother; 2022 Jul; 28(7):971-974. PubMed ID: 35184976
[TBL] [Abstract][Full Text] [Related]
8. Shedding of Viable Virus in Asymptomatic SARS-CoV-2 Carriers.
Murata T; Sakurai A; Suzuki M; Komoto S; Ide T; Ishihara T; Doi Y
mSphere; 2021 May; 6(3):. PubMed ID: 34011679
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of persisting SARS-CoV-2 infection in an immunocompromised patient with repeated nirmatrelvir/ritonavir courses: a case report.
Lindahl AL; Ahava MJ; Haukipää M; Kreivi HR; Lipponen A; Kortela E
Infect Dis (Lond); 2023 Aug; 55(8):585-589. PubMed ID: 37334428
[TBL] [Abstract][Full Text] [Related]
10. Assessing Viral Shedding and Infectivity of Asymptomatic or Mildly Symptomatic Patients with COVID-19 in a Later Phase.
Sohn Y; Jeong SJ; Chung WS; Hyun JH; Baek YJ; Cho Y; Kim JH; Ahn JY; Choi JY; Yeom JS
J Clin Med; 2020 Sep; 9(9):. PubMed ID: 32927798
[TBL] [Abstract][Full Text] [Related]
11. Prolonged COVID-19 in a Multiple Sclerosis Patient Treated With Rituximab.
Kintrilis N; Gkinos CP; Galinos I
Cureus; 2022 Dec; 14(12):e32523. PubMed ID: 36654638
[TBL] [Abstract][Full Text] [Related]
12. Year-long COVID-19 infection reveals within-host evolution of SARS-CoV-2 in a patient with B cell depletion.
Nussenblatt V; Roder AE; Das S; de Wit E; Youn JH; Banakis S; Mushegian A; Mederos C; Wang W; Chung M; Pérez-Pérez L; Palmore T; Brudno JN; Kochenderfer JN; Ghedin E
medRxiv; 2021 Oct; ():. PubMed ID: 34642697
[TBL] [Abstract][Full Text] [Related]
13. An approach to lifting self-isolation for health care workers with prolonged shedding of SARS-CoV-2 RNA.
Laferl H; Kelani H; Seitz T; Holzer B; Zimpernik I; Steinrigl A; Schmoll F; Wenisch C; Allerberger F
Infection; 2021 Feb; 49(1):95-101. PubMed ID: 33025521
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for redetectable positivity in recovered COVID-19 children.
Peng D; Zhang J; Ji Y; Pan D
Pediatr Pulmonol; 2020 Dec; 55(12):3602-3609. PubMed ID: 33049115
[TBL] [Abstract][Full Text] [Related]
15. Prolonged SARS-CoV-2 infection following rituximab treatment: clinical course and response to therapeutic interventions correlated with quantitative viral cultures and cycle threshold values.
Thornton CS; Huntley K; Berenger BM; Bristow M; Evans DH; Fonseca K; Franko A; Gillrie MR; Lin YC; Povitz M; Shafey M; Conly JM; Tremblay A
Antimicrob Resist Infect Control; 2022 Feb; 11(1):28. PubMed ID: 35123573
[TBL] [Abstract][Full Text] [Related]
16. Severe relapse of SARS-CoV-2 infection in a kidney transplant recipient with negative nasopharyngeal SARS-CoV-2 RT-PCR after rituximab.
Morel A; Imbeaud S; Scemla A; Péré H; Fourgeaud J; Amrouche L; Robillard N; Planas D; Puech J; Simon S; Lanternier F; Bélec L; Zuber J; Schwartz O; Anglicheau D; Chavarot N; Veyer D
Am J Transplant; 2022 Aug; 22(8):2099-2103. PubMed ID: 35150193
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.
Wei J; Zhao J; Han M; Meng F; Zhou J
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32727811
[TBL] [Abstract][Full Text] [Related]
18. Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients.
Ling Y; Xu SB; Lin YX; Tian D; Zhu ZQ; Dai FH; Wu F; Song ZG; Huang W; Chen J; Hu BJ; Wang S; Mao EQ; Zhu L; Zhang WH; Lu HZ
Chin Med J (Engl); 2020 May; 133(9):1039-1043. PubMed ID: 32118639
[TBL] [Abstract][Full Text] [Related]
19. Detectable Duration of Viable SARS-CoV-2, Total and Subgenomic SARS-CoV-2 RNA in Noncritically Ill COVID-19 Patients: a Prospective Cohort Study.
Phuphuakrat A; Pasomsub E; Srichatrapimuk S; Kirdlarp S; Suksatu A; Srisaowakarn C; Manopwisedjaroen S; Ludowyke N; Purwono PB; Priengprom T; Wongsa A; Thakkinstian A; Hongeng S; Malathum K; Thitithanyanont A; Tassaneetrithep B
Microbiol Spectr; 2022 Jun; 10(3):e0050322. PubMed ID: 35604133
[TBL] [Abstract][Full Text] [Related]
20. Diabetes mellitus is a risk factor for prolonged SARS-CoV-2 viral shedding in lower respiratory tract samples of critically ill patients.
Buetti N; Trimboli P; Mazzuchelli T; Lo Priore E; Balmelli C; Trkola A; Conti M; Martinetti G; Elzi L; Ceschi A; Consonni V; Ogna A; Forni-Ogna V; Bernasconi E
Endocrine; 2020 Dec; 70(3):454-460. PubMed ID: 32870469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
